Le Lézard
Classified in: Health
Subjects: AWD, NPT

Honourees Celebrated at 2017 Health Research Foundation Research Awards Gala


MONTREAL, Nov. 22, 2017 /CNW/ - The Health Research Foundation (HRF) of Innovative Medicines Canada, along with Prix Galien and Research Canada: An Alliance for Health Discovery, are proud to announce the winners of this year's pre-eminent Canadian health awards.

Logo: Health Research Foundation (CNW Group/Health Research Foundation)

These awards recognize and celebrate the best and brightest minds and discoveries in the Canadian life sciences sector. A recent analysis performed by EY Canada was completed to determine the economic impact of Innovative Medicines Canada's members.

Key highlights include:

The winners of this year's awards are:

HRF Medal of Honour

Dr. Ian Stiell - Dr. Stiell is a clinical epidemiologist and an emergency medicine physician whose focus on health services research in emergency medicine has had a direct impact on countless lives in Canada and abroad. He leads the Ottawa Hospital Emergency Medicine Research Group. His research has changed the way emergency room doctors across the world diagnose certain patients. Dr. Stiell obtained his Doctor of Medicine degree from the University of Western Ontario in 1975, and his Master of Science (Epidemiology), from the University of Ottawa in 1991. He has published 302 peer-reviewed papers in high-impact journals and has won many international awards that include election into the U.S. Institute of Medicine.

Research Canada Leadership in Advocacy Award

Dr. Eleanor Fish and Dr. Christopher Paige - Both winners were chosen based on their impact on advancing health research through their advocacy efforts. Dr. Fish has had a tremendous impact through the media by helping Canadians understand the benefits of Canadian health research to their everyday lives. Dr. Paige has built partnerships and promoted health research and health innovation policies through a number of organizations and institutions with which he has been affiliated, and, in some cases, created.

Prix Galien Canada Research Award

Dr. Ernesto Schiffrin - Dr. Schiffrin is one of Canada's most outstanding clinician scientists whose bench to bedside insights into the mechanisms and therapy of hypertension have had a transformative effect on our understanding and management of cardiovascular disease. His laboratory has elucidated the differential beneficial effects of ACE inhibitors, angiotension receptor antagonists, mineralocorticoid receptor blockers and calcium channel antagonists on vascular structure and endothelial function in essential hypertension and diabetes. 

Prix Galien Canada Innovative Product Award

The Prix Galien Canada - Innovative Product Award was given to Merck Canada Inc. for Pembrolizumab (Keytruda) which is a highly selective humanized anti-programmed cell death receptor antibody that restores T-cell mediated immune response against different types of cancer cells including advanced non-small cell lung cancer. The research and development of this drug involved two Canadian principal investigators, authorship on significant publications, partnership with six reference laboratories across the country to provide standardized PD-L1 testing, and enrollment of over 100 patients in 25 clinical trial centres.

Quick Facts

About the Health Research Foundation of Innovative Medicines Canada

The Health Research Foundation (HRF) is a non-profit organization whose mission is to support and promote the value of health research in Canada. By applying the highest standards of scientific excellence, addressing health system sustainability challenges and establishing partnerships, the HRF, one of the leading private health research foundations in the country, contributes significantly to the prevention and treatment of disease, to a better health care system and the availability for Canadians to access effective health products.

About The Prix Galien

The Prix Galien is the most prestigious award in the field of Canadian pharmaceutical research and innovation. Referred to as the Nobel Prize of pharmaceutical research, it recognizes the efforts and achievements of pharmaceutical research and development. The Prix Galien Canada is organized by Innovation Life Canada, a non-profit organization whose mission is to celebrate Canadian innovation in the life sciences.

About Research Canada

Research Canada: An Alliance for Health Discovery, is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is a shared benefit, shared responsibility and an investment in Canada's future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding ? investments that strengthen Canada's innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians. Only through sustained and balanced investments in health research will Canada succeed in keeping its citizens the healthiest and most prosperous in the world.

 

Left to right: Dr. Augusto Villanueva, Merck Canada Inc.;  Dr. Bradly Wouters on behalf of Dr. Christopher Paige; Dr. Eleanor Fish; Dr. Ernesto Schiffrin; Dr. Ian Stiell; Kristin Wall, Norton Rose Fulbright; Pamela Fralick, Innovative Medicines Canada; Hugh Scott, Health Research Foundation (CNW Group/Health Research Foundation)

SOURCE Health Research Foundation


These press releases may also interest you

at 05:00
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...

at 04:58
Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the use of high-speed atomic force microscopy helps to understand the crucial role played by certain biomolecules in DNA wrapping dynamics. In...

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...



News published on and distributed by: